Related Experiment Videos
The tissue-engineered vascular graft using bone marrow without culture.
Narutoshi Hibino1, Toshiharu Shin'oka, Goki Matsumura
1Department of Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women's Medical University, 8-1 Kawada, Shinjuku, Tokyo, Japan.
Summary
Tissue-engineered vascular grafts using bone marrow cells are a promising alternative to traditional methods. This approach simplifies graft creation, reducing costs and labor while maintaining tissue quality.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Vascular Surgery
Background:
- Current tissue-engineered vascular grafts face challenges with high costs and extensive labor for cell harvesting and culturing.
- Previous methods utilizing vascular mixed cells for graft creation were effective but resource-intensive.
Purpose of the Study:
- To develop a more efficient and cost-effective method for creating tissue-engineered vascular grafts.
- To evaluate the efficacy of using readily available bone marrow cells without the need for cell culture.
Main Methods:
- Biodegradable polymer scaffolds were seeded with either cultured venous cells (group V), unprocessed bone marrow cells (group B), or left unseeded (group C).
- These grafts were implanted into the inferior vena cavae of dogs and explanted after 4 weeks for histological and biochemical analysis.
Main Results:
- Histological examination revealed a well-formed collagen fiber layer and endothelial lining in grafts from groups V and B, similar to native vascular tissue.
- Group C (unseeded) showed significantly lower 4-hydroxyproline levels compared to groups V and B, indicating reduced collagen content.
- DNA content tended to be higher in the unseeded grafts (group C) than in cell-seeded grafts or native tissue.
Conclusions:
- Utilizing bone marrow cells for tissue-engineered vascular grafts is a viable and superior method compared to using cultured vascular cells.
- Bone marrow cells can be directly used without prior culture, simplifying the process and reducing associated burdens.
- This novel approach offers a more practical and efficient solution for vascular graft engineering.